Medicines for Europe Calls Out Threat Of Generics Supply Consolidation In EU Market
Trade Group Urges EU Intervention To Strengthen Supply Chain
Off-patent drugs industry trade group Medicines for Europe has penned an open letter to the EU containing several suggestions for how the union might tackle supply chain pressures in the generics sector.
You may also be interested in...
Medicines for Europe has expressed its support for a non-paper already adhered to by 21 EU member states, which proposes a number of solutions which could improve security of supply for medicines in the region.
The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance.
The ABPI, which represents the R&D-based pharmaceutical industry in the UK, says the proposed increase in the statutory scheme rebate sends "the worst possible signal" to global investors and boardrooms.